Adamax (984)
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Adamax (984)
Synthetic peptide designation for ACTH-related peptide research.
Overview
Adamax (984) is a research peptide designation associated with ACTH-related peptide analogues.
Chemical Identity & Research Overview
Adamax (984) is a synthetic peptide research designation associated with ACTH-related peptide analogues, with a focus on chemical identity and analytical characterization.
Key Highlights
- Triple-receptor agonist GLP-1R/GIPR/GCGR
- Lyophilized solid peptide,good stability
- Full batch-to-batch traceability,COA available for every lot
- Third-party tested, research-grade raw material
- ACTH-related peptide research
Safety & Side Effects
Adamax (984) is a research peptide designation associated with ACTH-related peptide analogues. When used in research, Adamax (984) should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published adamax (984) side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for peptide biochemistry readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for Adamax (984); it is supplied strictly for laboratory research. Reported adamax (984) dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document adamax (984) dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS Not Established, molecular formula Not Established, molecular weight 984 Da (designation)). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
How to Order
Enquiry
Send product code, strength and quantity for a fast quote.
Quotation
Receive price, lead time and specification.
QC & COA
Batch tested by HPLC/LC-MS; COA issued.
Delivery
Discreet, tracked worldwide shipping.
Specifications
| Product name | Adamax (984) |
|---|---|
| Product code | AX10 |
| Specification | 10mg*10vials |
| CAS number | Not Established |
| Molecular formula | Not Established |
| Molecular weight | 984 Da (designation) |
| Purity | ≥99% |
| Physical Form | Lyophilized Powder |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized material at −20°C, protected from light and moisture. Avoid repeated temperature fluctuations and freeze–thaw cycles.
Product Information Q&A
What is Adamax (984)?
Adamax (984) is a synthetic peptide research designation associated with ACTH-related peptide analogues. It is referenced by Medsafe alongside Semax in its discussion of ACTH analogues.
Is Adamax (984) the same as Semax?
No. Adamax (984) and Semax should not be treated as the same chemical identity. Semax has a defined public chemical record, while the chemical identity of Adamax (984) has not been consistently standardized in major public databases.
What does “984” refer to in Adamax (984)?
The “984” designation refers to the reported molecular-weight designation associated with this form of Adamax. It should be considered together with batch-specific analytical characterization.


